Current macro world conditions are surely guaranteed to cause uncertainty and caution in all segments of business, including
pharmaceuticals when funding and research in America are dealing with potential funds freeze, and the other problems of
staffing. It is impossible to think that investment by any company, does not factor to some degree, these situations. I feel sure
that there will be delays in FDA approvals and possibly, as happened in Covid times, certain pharmas who get preference or priority.
Its a new ballgame.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.3¢ |
Change
-0.001(3.85%) |
Mkt cap ! $93.33M | |||
| Open | High | Low | Value | Volume |
| 1.2¢ | 1.3¢ | 1.2¢ | $93.43K | 7.667M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 57 | 11875218 | 1.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.3¢ | 12506256 | 38 |
View Market Depth
| Last trade - 14.59pm 24/06/2025 (20 minute delay) ? |
| IMU (ASX) Chart |